Osaka Keisatsu Hospital

Osaka 543-8922

6 studies enrolling now · 8 studies all time

What they study most

Abdominal Aortic Aneurysm, Abdominal Aortic Aneurysm >= 5.0 Centimeters in Female (Disorder), Abdominal Aortic Aneurysm >= 5.5 Centimeters in Male (Disorder), Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a), Gastric Cancer, Gastroesophageal-junction Cancer, HER2-positive Gastric Cancer, Metabolic Dysfunction-Associated Steatotic Liver Disease, Moderate Aortic Valve Stenosis, Monoclonal Antibody, Peripheral Arterial Disease

Studies at this site

• Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a) — Recruiting now
• Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease — Recruiting now
• A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes) — Recruiting now
• Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature — Recruiting now
• Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial — Recruiting now
• A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer — Recruiting now
• A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a) — Running, not enrolling
• Evolut™ EXPAND TAVR II Pivotal Trial — Running, not enrolling